Avita Medical | 1811094D - Selling And Administration Expenses



Avita Medical reported AUD21.23M in Selling and Administration Expenses for its fiscal semester ending in December of 2024.


Selling And Administration Expenses Change Date
Adcock Ingram Holdings ZAR 1.05B 50.17M Dec/2024
Celltrion KRW 276.8B 58.09B Mar/2025
Clinuvel Pharmaceuticals AUD 16.21M 3.62M Jun/2024
Cochlear AUD 470M 4.4M Dec/2024
CSL USD 1.18B 201M Dec/2024
Cspc Pharmaceutical CNY 1.89B 347.81M Mar/2025
Dianthus Therapeutics USD 8.87M 2.04M Jun/2025
Divis Laboratories Ltd 3.4B 10M Jun/2025
Kangmei Pharma CNY 259.36M 49.8M Jun/2025
Knight Therapeutics CAD 25.48M 119K Sep/2024
Laboratorios Farma EUR 35.32M 2.75M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Mayne Pharma AUD 54.8M 11.94M Jun/2024
Medical Developments International AUD 12.94M 5.87M Dec/2024
Nanosonics AUD 50.26M 26.17M Dec/2024
Neuren Pharmaceuticals AUD 2.33M 47K Dec/2024
Organigram Holdings CAD 25.49M 8.3M Jun/2025
Pacific Edge NZD 19.43M 12.04M Sep/2024
Paradigm Biopharmaceuticals AUD 2.36M 639.57K Dec/2024
Pharma Mar EUR 14.68M 1M Jun/2025
Polynovo AUD 21.13M 18.27M Jun/2024
PYC Therapeutics AUD 2.58M 1.57M Dec/2024
Qiagen NV USD 148.74M 10.8M Jun/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
ResMed USD 265.12M 23.51M Jun/2025
Sartorius EUR 225.2M 6.7M Jun/2025
Sino Biopharmaceutical CNY 5.31B 1.54B Dec/2024
Telix Pharmaceuticals AUD 55.91M 31.78M Dec/2024
Tilray USD 72.38M 4.99M Nov/2024
Zz Pientze Pharmaceu -171290000 342.58M Jun/2025